Publication date: Available online 26 October 2026 Source: The Lancet Regional Health - Europe Author(s): Elias Péan, Martin Mengel, Filip Josephson, Daniel Zondag, Bruno Sepodes, Francesca Day
Daraxonrasib: a milestone for patients and European medicines regulation. // The Lancet Regional Health - Europe. – URL: https://www.sciencedirect.com/science/article/pii/S2666776226003261?dgcid=rss_sd_all
Daraxonrasib: a milestone for patients and European medicines regulation. The Lancet Regional Health - Europe. https://www.sciencedirect.com/science/article/pii/S2666776226003261?dgcid=rss_sd_all
“Daraxonrasib: a milestone for patients and European medicines regulation.” The Lancet Regional Health - Europe.
@article{article69342,
title = {Daraxonrasib: a milestone for patients and European medicines regulation},
journal = {The Lancet Regional Health - Europe},
url = {https://www.sciencedirect.com/science/article/pii/S2666776226003261?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...